WallStSmart

Park Ha Biological Technology Co., Ltd. (BYAH)vsUnilever PLC ADR (UL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 1990227% more annual revenue ($50.62B vs $2.54M). UL leads profitability with a 18.3% profit margin vs -214.2%. UL earns a higher WallStSmart Score of 48/100 (D+).

BYAH

Avoid

33

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -16.66

UL

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 8.5Value: 4.3Quality: 5.0
Piotroski: 4/9Altman Z: 2.20

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BYAH2 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
69.2%10/10

Every $100 of equity generates 69 in profit

Market CapQuality
$138.24B9/10

Large-cap with strong market position

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Free Cash FlowQuality
$1.76B8/10

Generating 1.8B in free cash flow

Areas to Watch

BYAH4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.5%4/10

1.5% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.92M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

UL4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
0.5%4/10

0.5% revenue growth

Debt/EquityHealth
1.983/10

Elevated debt levels

PEG RatioValuation
11.042/10

Expensive relative to growth rate

EPS GrowthGrowth
-5.6%2/10

Earnings declined 5.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : BYAH

The strongest argument for BYAH centers on Price/Book, Debt/Equity.

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 20.3%.

Bear Case : BYAH

The primary concerns for BYAH are Revenue Growth, EPS Growth, Market Cap.

Bear Case : UL

The primary concerns for UL are Revenue Growth, Debt/Equity, PEG Ratio. Debt-to-equity of 1.98 is elevated, increasing financial risk.

Key Dynamics to Monitor

BYAH profiles as a turnaround stock while UL is a value play — different risk/reward profiles.

BYAH is growing revenue faster at 1.5% — sustainability is the question.

UL generates stronger free cash flow (1.8B), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UL scores higher overall (48/100 vs 33/100), backed by strong 18.3% margins. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Park Ha Biological Technology Co., Ltd.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · China

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company is headquartered in Wuxi, the People's Republic of China.

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?